Overview

To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhinitis

Status:
Completed
Trial end date:
2003-10-01
Target enrollment:
Participant gender:
Summary
To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhinitis
Phase:
Phase 3
Details
Lead Sponsor:
UCB Pharma
Treatments:
Cetirizine
Levocetirizine
Loratadine